BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2357553)

  • 1. The response of suprachiasmatic neurons of the rat hypothalamus to photic and serotonergic stimulation.
    Miller JD; Fuller CA
    Brain Res; 1990 May; 515(1-2):155-62. PubMed ID: 2357553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin and the mammalian circadian system: I. In vitro phase shifts by serotonergic agonists and antagonists.
    Prosser RA; Dean RR; Edgar DM; Heller HC; Miller JD
    J Biol Rhythms; 1993; 8(1):1-16. PubMed ID: 8490207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The response of suprachiasmatic neurons of the rat hypothalamus to photic and nicotinic stimuli.
    Miller JD; Murakami DM; Fuller CA
    J Neurosci; 1987 Apr; 7(4):978-86. PubMed ID: 3572481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of the retinohypothalamic tract in the photic-like effects of the serotonin agonist quipazine in the rat.
    Graff C; Kohler M; Pévet P; Wollnik F
    Neuroscience; 2005; 135(1):273-83. PubMed ID: 16084651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of metergoline and quipazine on locomotor activity of rats in novel and familiar environments.
    Beninger RJ
    Pharmacol Biochem Behav; 1984 May; 20(5):701-5. PubMed ID: 6739514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of serotonergic agonists on firing rates of photically responsive cells in the hamster suprachiasmatic nucleus.
    Ying SW; Rusak B
    Brain Res; 1994 Jul; 651(1-2):37-46. PubMed ID: 7922588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local effects of the serotonin agonist quipazine on the suprachiasmatic nucleus of rats.
    Kalkowski A; Wollnik F
    Neuroreport; 1999 Oct; 10(15):3241-6. PubMed ID: 10574568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A serotonin agonist phase-shifts the circadian clock in the suprachiasmatic nuclei in vitro.
    Prosser RA; Miller JD; Heller HC
    Brain Res; 1990 Nov; 534(1-2):336-9. PubMed ID: 2073598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin agonist quipazine induces photic-like phase shifts of the circadian activity rhythm and c-Fos expression in the rat suprachiasmatic nucleus.
    Kohler M; Kalkowski A; Wollnik F
    J Biol Rhythms; 1999 Apr; 14(2):131-40. PubMed ID: 10194650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there a "serotonergic syndrome" in neonatal rat pups?
    Ristine LA; Spear LP
    Pharmacol Biochem Behav; 1985 Feb; 22(2):265-9. PubMed ID: 2858868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of metergoline and other serotonin receptor antagonists on serum corticosterone in rats.
    Fuller RW; Snoddy HD
    Endocrinology; 1979 Oct; 105(4):923-8. PubMed ID: 477605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of the behavioral effects of lysergic acid diethylamide, 2,5-dimethoxy-4-methylamphetamine, quipazine and lisuride by 5-hydroxytryptamine antagonists.
    Mokler DJ; Commissaris RL; Warner MR; Rech RH
    J Pharmacol Exp Ther; 1983 Dec; 227(3):557-62. PubMed ID: 6655557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of quipazine, a serotonin receptor agonist, on serum corticosterone concentration in rats.
    Fuller RW; Snoddy HD; Clemens JA
    Endocr Res Commun; 1978; 5(2):161-71. PubMed ID: 309816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of clonidine, quipazine, and LY 53857 on the prolactin-suppressant action of bromocriptine in rats.
    Lipham LB; Booth NH; Jernigan AD; Robbins JD; Hatch RC
    Am J Vet Res; 1986 May; 47(5):1089-91. PubMed ID: 3717731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin-mimetic and antidepressant drugs on passive avoidance learning by olfactory bulbectomised rats.
    Broekkamp CL; Garrigou D; LLoyd KG
    Pharmacol Biochem Behav; 1980 Nov; 13(5):643-6. PubMed ID: 6969405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonism of the behavioral effects of 2,5-dimethoxy-4-methylamphetamine (DOM) and quipazine by metergoline.
    Commissaris RL; Rech RH
    Pharmacol Biochem Behav; 1981 Oct; 15(4):659-62. PubMed ID: 7291270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonergic inhibition of light-induced fos protein expression and extracellular glutamate in the suprachiasmatic nuclei.
    Selim M; Glass JD; Hauser UE; Rea MA
    Brain Res; 1993 Sep; 621(2):181-8. PubMed ID: 7902183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quipazine and light have similar effects on c-fos induction in the rat suprachiasmatic nucleus.
    Moyer RW; Kennaway DJ; Ferguson SA; Dijstelbloem YP
    Brain Res; 1997 Aug; 765(2):337-42. PubMed ID: 9313909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further studies of serotonergic activity in the regulation of the cold stimulated thyrotropin secretion in male rats.
    Männistö PT; Tuominen RK
    Pharmacol Toxicol; 1988 Aug; 63(2):65-9. PubMed ID: 3186622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin-like actions of quipazine and CPP on spinal motoneurones.
    Neuman RS; White SR
    Eur J Pharmacol; 1982 Jun; 81(1):49-56. PubMed ID: 7117370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.